G-Finder Report: DNDi calls for increase in global R&D funding for NTDs on the first World NTD Day

The annual G-FINDER report, published on the first World NTD Day, showed that global funding for neglected disease R&D rose to $4 billion in 2018, the highest level ever recorded, and the first time that funding has grown for three consecutive years. However, funding for NTDs has been essentially flat for the past decade. In fact, it has gone backwards: funding for these diseases was almost 10% lower in 2018 than it was 2009, dropping by $34m, or 9.1%.

DNDi welcomes the findings of the 2019 G-FINDER report

30 January 2019
Geneva, Switzerland
The annual G-FINDER report provides policy-makers, donors, researchers, and industry with a comprehensive analysis of global investment into R&D of new products to prevent, diagnose, control, or cure neglected diseases in developing countries. It gives an up-to-date analysis of how R&D investments are being allocated across 36 neglected diseases, and product types, funding trends over time, and where the potential gaps lie.

3rd World Conference on Access to Medical Products

19-21 November 2019
New Delhi, India

  • Suman Rijal, Director of DNDi Regional Office – session on medical products for end game for HIV, TB, and malaria
  • Michelle Childs, Head of Policy Advocacy – session on antimicrobial resistance

World Health Summit 2019

27-29 October 2019
Berlin, Germany

  • Nathalie Strub-Wourgaft, NTD Director – workshops on sustainable elimination of NTDs and on co-creation and co-ownership of the UHC and SDG agendas
  • Monique Wasunna, Director of the DNDi Africa Regional Office – workshop on co-creation and co-ownership of the UHC and SDG agendas


16-20 September 2019
Liverpool, UK

  • DND– one symposium on cutaneous leishmaniasis and one on mycetoma
  • Nathalie Strub-Wourgaft, NTD Director – panel discussion on the future of research and development, satellite symposium on sleeping sickness